FIELD: veterinary science; pharmaceutics.
SUBSTANCE: invention refers to veterinary pharmaceutics, namely to a composition for humane intravenous euthanasia of animals. Composition for intravenous euthanasia of animals by humane method, containing a combination of hydrochlorides of tiletamine, xylazine and lidocaine, as well as the necessary auxiliary components, in the form of a lyophilisate for the preparation of a solution for injections or in the form of an injection solution in the following ratio of active ingredients in % by weight per 100 ml of the solution: tiletamine hydrochloride 0.05-0.5; xylazine hydrochloride 0.2-2.0; lidocaine hydrochloride 2.0-10.0.
EFFECT: specified invention allows to ensure compliance of the composition induced euthanasia procedure with humane criteria.
1 cl, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR HUMANE EUTHANASIA OF LABORATORY ANIMALS IN EXPERIMENT | 2024 |
|
RU2836552C1 |
| METHOD FOR ANAESTHETISATION IN RATS AT STAGED EXPERIMENT IN SIMULATED ENDOMETRIOSIS | 2011 |
|
RU2466753C1 |
| METHOD OF ANESTHESIA IN BALB/C NUDE MICE IN SURGICAL INTERVENTIONS | 2019 |
|
RU2712916C1 |
| MICROCOLLOIDAL SOLUTION OF PROPOFOL FOR ANAESTHESIA | 2013 |
|
RU2535001C1 |
| ANESTHETIC COMPOSITION COMPRISING NMDA-ANTAGONIST AND ALPHA-2-ADRENERGIC AGONIST | 2000 |
|
RU2244558C2 |
| GENERAL ANESTHETIC BASED ON 3-AMINOMETHYLENINDOLINON-2 | 2006 |
|
RU2326113C2 |
| USE OF MALTOSE MONOHYDRATE AS MAIN AUXILIARY SUBSTANCE IN INJECTABLE ANAESTHETIC BASED ON TYLETAMINE HYDROCHLORIDE AND ZOLAZEPAM HYDROCHLORIDE | 2024 |
|
RU2835318C1 |
| ANAESTHETIC COMPOSITION | 2011 |
|
RU2574022C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING DAMAGE BY NON-LETHAL IRRITANTS | 2011 |
|
RU2466721C1 |
| COMPOSITION FOR PREVENTING AND TREATING INFLAMMATORY DISEASES OF ORAL CAVITY | 2019 |
|
RU2716501C1 |
